Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas

This study describes the characterization of a novel kinase inhibitor, ON123300, which inhibits CDK4/6 and PI3K-δ and exhibits potent activity against mantle cell lymphomas (MCLs) both in vitro and in vivo. We examined the effects of PD0332991 and ON 123300 on cell cycle progression, modulation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Divakar, Saikrishna A., Reddy, M.V. Ramana, Cosenza, Stephen C., Baker, Stacey J., Perumal, Deepak, Antonelli, Anthony C., Brody, Joshua, Akula, Balaiah, Parekh, Samir, Reddy, E. Premkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703501/
https://www.ncbi.nlm.nih.gov/pubmed/26174628
http://dx.doi.org/10.1038/leu.2015.185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703501/
https://www.ncbi.nlm.nih.gov/pubmed/26174628
http://dx.doi.org/10.1038/leu.2015.185

Ejemplares similares